AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
ANALYSIS OF 461 UNRELATED NMDP DONORS OVER THE LAST 3 YEARS FROM A SINGLE COLLECTION CENTER - SIGNIFICANT DIFFERENCES BETWEEN MALE AND FEMALE DONORS
Authors: AREMAN EM RHODES PL MEEHAN KR BADROS A FRANKEL S GLASER M SACHER R SPITZER G CAIRO M
Citation: Em. Areman et al., ANALYSIS OF 461 UNRELATED NMDP DONORS OVER THE LAST 3 YEARS FROM A SINGLE COLLECTION CENTER - SIGNIFICANT DIFFERENCES BETWEEN MALE AND FEMALE DONORS, Experimental hematology, 26(8), 1998, pp. 360-360
IDIOPATHIC GIANT-CELL MYOCARDITIS AFTER AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION AND INTERLEUKIN-2 IMMUNOTHERAPY - A CASE-REPORT
Authors: TRUICA CI HANSEN CH GARVIN DF MEEHAN KR
Citation: Ci. Truica et al., IDIOPATHIC GIANT-CELL MYOCARDITIS AFTER AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION AND INTERLEUKIN-2 IMMUNOTHERAPY - A CASE-REPORT, Cancer, 83(6), 1998, pp. 1231-1236
IDIOPATHIC GIANT-CELL MYOCARDITIS AFTER AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION AND INTERLEUKIN-2 IMMUNOTHERAPY - A CASE-REPORT (VOL 83, PG 1231, 1998)
Authors: TRUICA CI HANSEN CH GARVIN DF MEEHAN KR
Citation: Ci. Truica et al., IDIOPATHIC GIANT-CELL MYOCARDITIS AFTER AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION AND INTERLEUKIN-2 IMMUNOTHERAPY - A CASE-REPORT (VOL 83, PG 1231, 1998), Cancer, 83(10), 1998, pp. 2239-2240
A PILOT-STUDY EVALUATING INTERLEUKIN-2-ACTIVATED HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES
Authors: MEEHAN KR BADROS A FRANKEL SR CAHILL R AREMAN E JENSON M SACHER R MAZUMDER A
Citation: Kr. Meehan et al., A PILOT-STUDY EVALUATING INTERLEUKIN-2-ACTIVATED HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES, Journal of hematotherapy, 6(5), 1997, pp. 457-464
ACCESS TO BONE-MARROW TRANSPLANTATION FOR LEUKEMIA AND LYMPHOMA - THEROLE OF SOCIODEMOGRAPHIC FACTORS
Authors: MITCHELL JM MEEHAN KR KONG J SCHULMAN KA
Citation: Jm. Mitchell et al., ACCESS TO BONE-MARROW TRANSPLANTATION FOR LEUKEMIA AND LYMPHOMA - THEROLE OF SOCIODEMOGRAPHIC FACTORS, Journal of clinical oncology, 15(7), 1997, pp. 2644-2651
INTERLEUKIN-2-ACTIVATED HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR BREAST-CANCER - INVESTIGATION OF DOSE LEVEL WITH CLINICAL CORRELATES
Authors: MEEHAN KR VERMA UN CAHILL R FRANKEL S AREMAN EM SACHER RA FOELBER R RAJAGOPAL C GEHAN EA LIPPMAN ME MAZUMDER A
Citation: Kr. Meehan et al., INTERLEUKIN-2-ACTIVATED HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR BREAST-CANCER - INVESTIGATION OF DOSE LEVEL WITH CLINICAL CORRELATES, Bone marrow transplantation, 20(8), 1997, pp. 643-651
SUPPRESSION OF PROGENITOR-CELL GROWTH BY VANCOMYCIN FOLLOWING AUTOLOGOUS STEM-CELL TRANSPLANTATION
Authors: MEEHAN KR VERMA UN ESTEVALORENZO F MAZUMDER A
Citation: Kr. Meehan et al., SUPPRESSION OF PROGENITOR-CELL GROWTH BY VANCOMYCIN FOLLOWING AUTOLOGOUS STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 19(10), 1997, pp. 1029-1032
PREAPHERESIS LEVELS OF PERIPHERAL-BLOOD CD34-BLOOD PROGENITOR CELLS IN AUTOLOGOUS PATIENTS( CELLS CORRELATE WITH CD34+ PERIPHERAL)
Authors: AREMAN EM MEEHAN KR SACHER RA
Citation: Em. Areman et al., PREAPHERESIS LEVELS OF PERIPHERAL-BLOOD CD34-BLOOD PROGENITOR CELLS IN AUTOLOGOUS PATIENTS( CELLS CORRELATE WITH CD34+ PERIPHERAL), Transfusion, 37(11-12), 1997, pp. 1217-1217
CYTOKINETIC STUDIES OF ADULT BONE-MARROW, FETAL BONE-MARROW, PERIPHERAL-BLOOD AND CORD-BLOOD - HIGH PROLIFERATIVE WITH FETAL BONE-MARROW
Authors: WUL AG MICHEJDA M MEEHAN KR MAZUMDER A BELLANTIL JA
Citation: Ag. Wul et al., CYTOKINETIC STUDIES OF ADULT BONE-MARROW, FETAL BONE-MARROW, PERIPHERAL-BLOOD AND CORD-BLOOD - HIGH PROLIFERATIVE WITH FETAL BONE-MARROW, Blood, 90(10), 1997, pp. 3399-3399
ENHANCEMENT OF TUMOR CELL-DIRECTED CYTOTOXICITY AND PURGING BY ACTIVATION OF HUMAN PERIPHERAL-BLOOD STEM-CELLS (PBSC) WITH COMBINATIONS OF CYTOKINES
Authors: MEEHAN KR HASSAN R WU AG CHAWLA J HERSCOWITZ HB
Citation: Kr. Meehan et al., ENHANCEMENT OF TUMOR CELL-DIRECTED CYTOTOXICITY AND PURGING BY ACTIVATION OF HUMAN PERIPHERAL-BLOOD STEM-CELLS (PBSC) WITH COMBINATIONS OF CYTOKINES, Blood, 90(10), 1997, pp. 4173-4173
COSTS OF AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATIONCAN BE REDUCED BY PB CD34 SCREENING BEFORE APHERESIS
Authors: AREMAN EM RHODES PL MEEHAN KR SACHER RA
Citation: Em. Areman et al., COSTS OF AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATIONCAN BE REDUCED BY PB CD34 SCREENING BEFORE APHERESIS, Blood, 90(10), 1997, pp. 4198-4198
PRIMING WITH HIGH-DOSE PACLITAXEL AND RHG-CSF FOR BREAST-CANCER PATIENTS
Authors: MEEHAN KR EBADITEHRANI M AREMAN EA BADROS A GRIFFITH K FRANKEL S RAJAGOPAL C SPITZER G
Citation: Kr. Meehan et al., PRIMING WITH HIGH-DOSE PACLITAXEL AND RHG-CSF FOR BREAST-CANCER PATIENTS, Blood, 90(10), 1997, pp. 4239-4239
LATE INITIATION OF RHG-CSF FOLLOWING AUTOLOGOUS PBSCT DOES NOT DELAY ENGRAFTMENT
Authors: ERICSON SG MEEHAN KR
Citation: Sg. Ericson et Kr. Meehan, LATE INITIATION OF RHG-CSF FOLLOWING AUTOLOGOUS PBSCT DOES NOT DELAY ENGRAFTMENT, Blood, 90(10), 1997, pp. 4362-4362
PERIPHERAL-BLOOD (PB) CD34 AS A PREDICTOR OF HEMATOPOIETIC PROGENITORCELLS (HPC) IN PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTIONS
Authors: AREMAN EM MEEHAN KR SACHER RA
Citation: Em. Areman et al., PERIPHERAL-BLOOD (PB) CD34 AS A PREDICTOR OF HEMATOPOIETIC PROGENITORCELLS (HPC) IN PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTIONS, Blood, 90(10), 1997, pp. 942-942
ALLOGENEIC BONE-MARROW TRANSPLANTATION IN A PATIENT WITH HYPEREOSINOPHILIC SYNDROME
Authors: ESTEVALORENZO FJ MEEHAN KR SPITZER TR MAZUMDER A
Citation: Fj. Estevalorenzo et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION IN A PATIENT WITH HYPEREOSINOPHILIC SYNDROME, American journal of hematology, 51(2), 1996, pp. 164-165
HEMATOPOIETIC POTENTIAL OF IL-2-CULTURED PERIPHERAL-BLOOD STEM-CELLS FROM BREAST-CANCER PATIENTS
Authors: AREMAN EM MAZUMDER A KOTULA PL VERMA UN RAJAGOPAL C HANCOCK S GUEVARRA C DJAHANMIR M SACHER RA MEEHAN KR
Citation: Em. Areman et al., HEMATOPOIETIC POTENTIAL OF IL-2-CULTURED PERIPHERAL-BLOOD STEM-CELLS FROM BREAST-CANCER PATIENTS, Bone marrow transplantation, 18(3), 1996, pp. 521-525
BONE-MARROW VOLUME AND THE USE OF AUTOLOGOUS BLOOD-TRANSFUSIONS (ABT)IN UNRELATED DONORS
Authors: CAHILL RA HERBST J MEEHAN KR RAJAGOPAL C AREMAN E MAZUMDER A HARTZMAN R
Citation: Ra. Cahill et al., BONE-MARROW VOLUME AND THE USE OF AUTOLOGOUS BLOOD-TRANSFUSIONS (ABT)IN UNRELATED DONORS, Blood, 88(10), 1996, pp. 3841-3841
EFFECT OF 24-HOUR CULTURE WITH INTERLEUKIN-2 (IL2) ON PROGENITOR CELLS IN AUTOLOGOUS BONE-MARROW (ABM) AND PERIPHERAL-BLOOD STEM-CELLS (PBSC) FROM PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
Authors: AREMAN EM KOTULARHODES P RAJAGOPAL C MEEHAN KR MAZUMDER A SACHER RA
Citation: Em. Areman et al., EFFECT OF 24-HOUR CULTURE WITH INTERLEUKIN-2 (IL2) ON PROGENITOR CELLS IN AUTOLOGOUS BONE-MARROW (ABM) AND PERIPHERAL-BLOOD STEM-CELLS (PBSC) FROM PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, Blood, 88(10), 1996, pp. 437-437
SURVIVAL FOLLOWING INTERLEUKIN-2 (IL-2) ACTIVATED AUTOLOGOUS PBSC TRANSPLANTATION AND POST TRANSPLANT IL-2 THERAPY IN WOMEN WITH BREAST-CANCER
Authors: MEEHAN KR VERMA UN ARUNKILIC B FRANKEL SR RAJAGOPAL C CAHILL R JENSEN M LIPPMAN ME MAZUMDER A
Citation: Kr. Meehan et al., SURVIVAL FOLLOWING INTERLEUKIN-2 (IL-2) ACTIVATED AUTOLOGOUS PBSC TRANSPLANTATION AND POST TRANSPLANT IL-2 THERAPY IN WOMEN WITH BREAST-CANCER, Blood, 88(10), 1996, pp. 497-497
SURVIVAL FOR STAGE IIIB BREAST-CANCER FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION(PBSCT)
Authors: ARUNKILIC B SPITZER TR RAJAGOPAL C MCAFEE S LIPPMAN ME MAZUMDER A MEEHAN KR
Citation: B. Arunkilic et al., SURVIVAL FOR STAGE IIIB BREAST-CANCER FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION(PBSCT), Blood, 88(10), 1996, pp. 498-498
ACCESS TO BONE-MARROW TRANSPLANTATION (BMT) FOR LEUKEMIA AND LYMPHOMA- THE ROLE OF SOCIODEMOGRAPHIC FACTORS
Authors: MEEHAN KR MITCHELL JM KONG J SCHULMAN KA
Citation: Kr. Meehan et al., ACCESS TO BONE-MARROW TRANSPLANTATION (BMT) FOR LEUKEMIA AND LYMPHOMA- THE ROLE OF SOCIODEMOGRAPHIC FACTORS, Blood, 88(10), 1996, pp. 2425-2425
STUDIES OF POSSIBLE MECHANISMS FOR THE EFFECT OF UROKINASE THERAPY INSMALL-CELL CARCINOMA OF THE LUNG
Authors: MEEHAN KR ZACHARSKI LR MAURER LH HOWELL AL MEMOLI VA ROUSSEAU SM HUNT JA HENKIN J
Citation: Kr. Meehan et al., STUDIES OF POSSIBLE MECHANISMS FOR THE EFFECT OF UROKINASE THERAPY INSMALL-CELL CARCINOMA OF THE LUNG, Blood coagulation & fibrinolysis, 6(2), 1995, pp. 105-112
AUTOLOGOUS BONE-MARROW TRANSPLANTATION VERSUS CHEMOTHERAPY IN RELAPSED REFRACTORY NON-HODGKINS-LYMPHOMA - ESTIMATES OF LONG-TERM SURVIVAL FROM THE RECENT LITERATURE
Authors: MEEHAN KR PRITCHARD RS LEICHTER JW LITTENBERG B WELCH HG
Citation: Kr. Meehan et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION VERSUS CHEMOTHERAPY IN RELAPSED REFRACTORY NON-HODGKINS-LYMPHOMA - ESTIMATES OF LONG-TERM SURVIVAL FROM THE RECENT LITERATURE, American journal of hematology, 50(2), 1995, pp. 116-123
PRETREATMENT FIBRINOGEN LEVELS ARE ASSOCIATED WITH RESPONSE TO CHEMOTHERAPY IN PATIENTS WITH SMALL-CELL CARCINOMA OF THE LUNG - DEPARTMENT-OF-VETERANS-AFFAIRS COOPERATIVE STUDY-188
Authors: MEEHAN KR ZACHARSKI LR MORITZ TE RICKLES FR
Citation: Kr. Meehan et al., PRETREATMENT FIBRINOGEN LEVELS ARE ASSOCIATED WITH RESPONSE TO CHEMOTHERAPY IN PATIENTS WITH SMALL-CELL CARCINOMA OF THE LUNG - DEPARTMENT-OF-VETERANS-AFFAIRS COOPERATIVE STUDY-188, American journal of hematology, 49(2), 1995, pp. 143-148
ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC) FUNCTION OF PERIPHERAL-BLOOD POLYMORPHONUCLEAR NEUTROPHILS (PMN) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)
Authors: ERICSON SG GUYRE CA BENOIT NE MEEHAN KR MILLS LE FANGER MW
Citation: Sg. Ericson et al., ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC) FUNCTION OF PERIPHERAL-BLOOD POLYMORPHONUCLEAR NEUTROPHILS (PMN) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT), Bone marrow transplantation, 16(6), 1995, pp. 787-791
Risultati: 1-25 | 26-34